Ind-Swift Laboratories gains on getting nod to sell M/s Halcyon life Sciences

31 Mar 2023 Evaluate

Ind-Swift Laboratories is currently trading at Rs. 55.98, up by 0.55 points or 0.99% from its previous closing of Rs. 55.43 on the BSE.

The scrip opened at Rs. 54.25 and has touched a high and low of Rs. 56.32 and Rs. 54.25 respectively. So far 511 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 77.00 on 05-Apr-2022 and a 52 week low of Rs. 51.10 on 31-May-2022.

Last one week high and low of the scrip stood at Rs. 58.80 and Rs. 54.03 respectively. The current market cap of the company is Rs. 332.78 crore.

The promoters holding in the company stood at 42.00%, while Institutions and Non-Institutions held 19.53% and 38.47% respectively.

Ind-Swift Laboratories has received approval from board of directors to sell wholly owned subsidiary namely ‘M/s. Halcyon life Sciences’ to ‘M/s. RN Chemicals & Pharmaceutical’ for Rs 50 lakh. The Audit Committee and Board of the Directors of the Company at its meeting held on March 30, 2023 has approved the same.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).

Ind-Swift Lab. Share Price

91.74 -0.08 (-0.09%)
26-Dec-2025 15:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.75
Dr. Reddys Lab 1268.85
Cipla 1504.50
Zydus Lifesciences 911.80
Lupin 2110.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×